INDIAN PHARMACEUTICAL INDUSTRY IS TENSE AS TRUMP’S APRIL 2 DEADLINE APPROACHES
U.S. DRUG MARKET IN TURMOIL SINCE CONSUMERS HAVE TO PAY MORE FOR TARIFF HIKE
2025-03-20 15:54
-
NEW YORK: Can India follow the Chinese model with retaliatory tariffs against the US duties on Indian goods as US president Donald Trump, despite his bonhomie with Indian premier Narendra Modi, publicly declared that Indian tariffs on US products were among the highest and so why not increase the tariffs on Indian products.